These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29385873)

  • 1. Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.
    Kamiyama R; Yoshimi R; Takeno M; Iribe Y; Tsukahara T; Kishimoto D; Kunishita Y; Sugiyama Y; Tsuchida N; Nakano H; Minegishi K; Tamura M; Asami Y; Kirino Y; Ishigatsubo Y; Ozato K; Nakajima H
    Mod Rheumatol; 2018 Nov; 28(6):993-1003. PubMed ID: 29385873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors.
    Sjöstrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
    J Immunol; 2013 Oct; 191(7):3753-63. PubMed ID: 23975864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TRIM21 antibody is associated with aberrant B-cell function and type I interferon production in systemic lupus erythematosus.
    Kunishita Y; Yoshimi R; Kamiyama R; Kishimoto D; Komiya T; Sakurai N; Sugiyama Y; Takase-Minegishi K; Kirino Y; Nagaoka S; Nakajima H
    Lupus; 2021 Nov; 30(13):2054-2065. PubMed ID: 34565210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
    Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
    Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher activation of the interferon-gamma signaling pathway in systemic lupus erythematosus patients with a high type I IFN score: relation to disease activity.
    Liu M; Liu J; Hao S; Wu P; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2018 Oct; 37(10):2675-2684. PubMed ID: 29774490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE).
    Csiszár A; Nagy G; Gergely P; Pozsonyi T; Pócsik E
    Clin Exp Immunol; 2000 Dec; 122(3):464-70. PubMed ID: 11122256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells.
    Karonitsch T; Feierl E; Steiner CW; Dalwigk K; Korb A; Binder N; Rapp A; Steiner G; Scheinecker C; Smolen J; Aringer M
    Arthritis Rheum; 2009 May; 60(5):1463-71. PubMed ID: 19404947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
    Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
    Front Immunol; 2018; 9():3085. PubMed ID: 30666255
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons.
    Stone RC; Feng D; Deng J; Singh S; Yang L; Fitzgerald-Bocarsly P; Eloranta ML; Rönnblom L; Barnes BJ
    Arthritis Rheum; 2012 Mar; 64(3):788-98. PubMed ID: 21968701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
    Hua J; Kirou K; Lee C; Crow MK
    Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-α production in SLE patients.
    Mortezagholi S; Babaloo Z; Rahimzadeh P; Namdari H; Ghaedi M; Gharibdoost F; Mirzaei R; Bidad K; Salehi E
    Immunopharmacol Immunotoxicol; 2017 Feb; 39(1):11-18. PubMed ID: 28049380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.
    Lin LH; Ling P; Liu MF
    J Rheumatol; 2011 Sep; 38(9):1914-9. PubMed ID: 21632682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
    Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
    Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
    Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
    Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
    Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
    Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factors in human lupus pathogenesis.
    Salloum R; Niewold TB
    Transl Res; 2011 Jun; 157(6):326-31. PubMed ID: 21575916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
    Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
    Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor 9 is correlated to disease activity in Chinese systemic lupus erythematosus population.
    Mu R; Sun XY; Lim LT; Xu CH; Dai CX; Su Y; Jia RL; Li ZG
    Chin Med J (Engl); 2012 Aug; 125(16):2873-7. PubMed ID: 22932083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas-associated death domain (FADD) and the E3 ubiquitin-protein ligase TRIM21 interact to negatively regulate virus-induced interferon production.
    Young JA; Sermwittayawong D; Kim HJ; Nandu S; An N; Erdjument-Bromage H; Tempst P; Coscoy L; Winoto A
    J Biol Chem; 2011 Feb; 286(8):6521-31. PubMed ID: 21183682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-like Aggregation of Mitochondrial Antiviral Signaling Protein in Lupus Patients Is Associated With Increased Levels of Type I Interferon.
    Shao WH; Shu DH; Zhen Y; Hilliard B; Priest SO; Cesaroni M; Ting JP; Cohen PL
    Arthritis Rheumatol; 2016 Nov; 68(11):2697-2707. PubMed ID: 27110677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.